|
Match
|
Document |
Document Title |
|
|
US20090312407 |
Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of Cancer and other Pathologies
A compound, pharmaceutical composition and method for the treatment of mammals wherein the active therapeutic agent is a compound having the structure:
wherein:
R 1 is an...
|
|
|
US20090312293 |
PROCESS FOR THE ISOLATION OF PHARMACOLOGICALLY ACTIVE PRINCIPLES OF VEGETABLE AND ANIMAL ORIGIN
A process for the recovery and purification of natural hydrophilic water-soluble products in conjugated form from vegetable aqueous extracts or physiological fluids, by adsorption of the extracts...
|
|
|
US20090306386 |
Plant Extract Obtained by an Extraction Method by Means of Solvents of Plant Origin
The invention relates to a plant extract obtained by a single-phase extraction method, by means of a solvent and/or a mixture of solvents of plant origin, containing characterised and chemically...
|
|
|
US20090306384 |
Process for the Production of Benzopyran-2-ol Derivatives
The invention provides a process for producing a compound of formula (I),
wherein Y is selected from the group consisting of CH 3 , CH 2 OH, CH 2 CH 2 OH, CH 2 Br and Br; comprising the steps...
|
|
|
US20090287001 |
Process for the Manufacture of Hydroxylated Isoflavones
A process for the preparation of hydroxylated isoflavones by reacting in a Hoesch reaction using an alkanoic acid alkyl ester as solvent a phenol with a phenylacetonitrile to yield a...
|
|
|
US20090259055 |
Catalytic enantioselective synthesis of flavanones and chromanones
Various chromanone, flavanone and abyssinone compounds as can be prepared enantioselectively using a chiral thiourea catalyst.
|
|
|
US20090258939 |
PYRONE ANALOG COMPOSITIONS AND METHODS
Novel pyrone analogs are described which can enhance the effectiveness of a therapeutic agent when administered and/or reduce side effects caused by the administration of a therapeutic agent.
|
|
|
US20090258942 |
CALYCOSIN AND ANALOGS THEREOF FOR THE TREATMENT OF ESTROGEN RECEPTOR BETA-MEDIATED DISEASES
Estrogenic compositions comprising calycosin and analogs thereof are provided. Also provided are methods of using said extracts to achieve an estrogenic effect, especially in a human, e.g. a female...
|
|
|
US20090232919 |
Composition Comprising Liquiritigenin for Preventing and Treating Liver Disease
The present invention is related to a composition comprising an extract of licorice or liquiritigenin isolated therefrom significantly decrease the blood concentration of LDH and ALT enzyme,...
|
|
|
US20090233998 |
Desmosdumotins, the Method for Preparing the Same and Use as Anti-Tumor or Anti-AIDS Agents
This invention discloses the method for preparing desmosdumotin C, the series of desmosdumotin C derivatives and their manufactures, and the total synthesis of desmosdumotin B. The invention also...
|
|
|
US20090227806 |
METHOD FOR PRODUCING NARINGENIN DERIVATIVES FROM XANTHOHUMOL
The present invention relates to an efficient method for producing naringenin derivatives from xanthohumol or derivatives thereof. In particular, the method according to the present invention...
|
|
|
US20090221696 |
COMPOSITION FOR TREATING CANCER CELLS AND PREPARATION METHOD FOR THE SAME
A composition for treating cancer cells and a preparation method therefor are provided. The novel flavonoid compounds are obtained from natural plants, and more particularly the compounds have a...
|
|
|
US20090221690 |
Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof
Osteoporosis is one of the major problems in our aging society. Osteoporosis results in bone fracture in older members of the population, especially in post-menopausal women. In traditional...
|
|
|
US20090221568 |
Synthesis of Inhibitors of FtsZ
FtsZ, the bacterial analog of tubulin, is a promising new target for developing new antibiotics. It has been shown that polyphenols inhibit the GTPase activity of FtsZ, thereby inhibiting Z-ring...
|
|
|
US20090215767 |
ISOFLAVONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
An isoflavone derivative is provided. The isoxazole derivative has following formula:
wherein R 1 and R 2 , independently, include C 1 -C 12 alkyl optionally substituted with oxirane,...
|
|
|
US20090209533 |
ALDH-2 INHIBITORS IN THE TREATMENT OF ADDICTION
Disclosed are novel isoflavone derivatives having the structure of Formula I
which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example...
|
|
|
US20090202668 |
Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae
The invention relates to the use of a polyphenol in the manufacture of a nutriceutical, a food, a food supplement or a medicament for the prophylactic or therapeutic treatment of endothelial...
|
|
|
US20090197943 |
Flavonoid Dimers and Methods of Making and Using Such
Multidrug resistance (MDR) is a major problem in cancer chemotherapy. The best characterized resistance mechanism is the one mediated by the over-expression of drug efflux transporters,...
|
|
|
US20090176871 |
Treatments for Domestic Animals Having Sex Hormone Deficiencies Using Soy Germ Isoflavones
The novel applicability and methods of use of soy germ extracted isoflavones for the treatment of sex hormone loss due to spaying, neutering and aging in domestic pets as well as service and guide...
|
|
|
US20090170927 |
FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM
The present invention relates to compounds of formula I, which are functionalized phenolic compounds, and polymers formed from the same.
|
|
|
US20090149530 |
Antiinfective Flavonol Compounds and Methods of Use Thereof
In one aspect of the invention, the antiinfective agents are flavonol compounds of the represented by formula I:
Another aspect of the invention is a method for treating an infection in a...
|
|
|
US20090131339 |
COMPOUNDS HAVING NEUROPROTECTIVE PROPERTIES
The invention relates to the use of morin and mangiferin, the pharmaceutically acceptable salts, prodrugs and/or solvates thereof in the production of a pharmaceutical composition for the...
|
|
|
US20090118164 |
METHODS AND COMPOUNDS FOR THE TARGETED DELIVERY OF AGENTS TO BONE FOR INTERACTION THEREWITH
Bone targeted compounds and methods are provided. Compounds can include a Bone Targeting Portion (R T ), having an affinity for bone; a Bone Active Portion (R A ) for interacting with and affecting...
|
|
|
US20090062555 |
Synthesis of Isoflavone
The invention provides a process of manufacturing an isoflavone of the general formula 7
wherein R 1 , R 2 , R 3 , and R 4 each independently are H, OH, or an alkoxy, provided at least one of R...
|
|
|
US20090054516 |
COMPOSITION FOR TREATING CANCER CELLS AND SYNTHETIC METHOD FOR THE SAME
A pharmaceutical composition having a cytotoxic effect to a cancer cell and a method for the same are provided. The pharmaceutical composition comprises a flavonoid compound having at least one of...
|
|
|
US20090028804 |
AhR mediators
The invention relates to a method for finding and assessing agonists [and] antagonists of the aryl hydrocarbon receptor (Ah receptor; AhR), to the agonists and antagonists themselves and to uses...
|
|
|
US20090030070 |
EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE
To increase a tissue regeneration ability of a living body such as a collagens production ability of fibroblast in the dermis in a skin defect area typified by a large wrinkle or wound, a flavanone...
|
|
|
US20090005324 |
Biologically active extract from dendrobium plant, use thereof and process for preparing the same
A substance having the following formula is provided.
wherein R 1 and R 2 are selected from a group consisting of α-Ara, β-Ara and β-Xyl. The substance has an effect of accelerating a...
|
|
|
US20080306286 |
Isolation, Purification and Synthesis of Procyanidin B2 and Uses Thereof
Methods for the synthesis, isolation, and purification of procyanidin B2 are disclosed. The synthetic methods utilize epicatechin as a starting material and produce procyanidin B2 in high yields....
|
|
|
US20080262080 |
Allergy Suppressive Agent
The present invention provides a novel agent/composition using a bioregulatory function of a food ingredient. Namely, it is intended to provide an allergy suppressive agent comprising chrysin,...
|
|
|
US20080261898 |
COMPOSITION AND METHOD FOR CANCER TREATMENT AND PREVENTION
Compounds, compositions, methods and kits are provided for treating, reducing the risk of, or preventing diseases and/or conditions, such as diseases associated with angiogenesis and/or abnormal...
|
|
|
US20080254149 |
Recovery of Residual Plant Components After Distillation of Essential Oils
Methods for recovering valuable compounds and substances from plants after distillation of oils are disclosed. The methods involve various aqueous and non-aqueous solvent extraction of plant...
|
|
|
US20080233242 |
Antioxidant of Bamboo Leaves and Its Uses
The present invention discloses the composition of antioxidant of bamboo leaves (AOB) and its use. The purpose of present invention is to provide a new food additive which is natural, nutritional,...
|
|
|
US20080194522 |
Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B)
The present invention relates to compounds useful for detecting the activity of monoamine oxidases, compounds useful for competitively inhibiting monoamine oxidases, for determining inhibitors of...
|
|
|
US20080188549 |
Composition for Preventing and/or Treating Metabolic Syndrome and Insulin Resistance Syndrome
The present invention has its object to provide a specific compound derived from a naturally occurring substance, and a composition for the prevention and/or treatment of metabolic syndrome and...
|
|
|
US20080114056 |
Chromone Derivatives Useful as Vanilloid Antagonists
The present invention relates to the use of a chromone compound of the formula
wherein
R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined in the specification and in the claims, in free...
|
|
|
US20080032995 |
ALDH-2 INHIBITORS IN THE TREATMENT OF DRUG ADDICTION
Disclosed are novel isoflavone derivatives having the structure of Formula I
which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example...
|
|
|
US20080026087 |
Litchi Sinensis Extracts Containing Oligomeric Proanthocyanidins and Processes of Making Thereof
A botanic extract of Litchi sinensis containing, based on active substance content, at least 15% by weight of an oligomeric proanthocyanidin of the OPC A2 type is disclosed. Processes of making...
|